TLR signaling in mast cells: common and unique features

被引:211
作者
Sandig, Hilary [1 ]
Bulfone-Paus, Silvia [1 ,2 ]
机构
[1] Univ Manchester, Fac Human Med Sci, Manchester M13 9RD, Lancs, England
[2] Res Ctr, Dept Immunol & Cell Biol, Borstel, Germany
来源
FRONTIERS IN IMMUNOLOGY | 2012年 / 3卷
关键词
cytokine; innate; mast cells; review; signaling; TLRs;
D O I
10.3389/fimmu.2012.00185
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In addition to the well known role of mast cells in immunity to multi-cellular parasites and in the pathogenesis of allergy and asthma, the importance of mast cells in the immune defense against bacteria and viruses is increasingly being recognized. Their location in the skin, gut, and airways puts mast cells in an ideal location to encounter and respond to pathogens, and in order to perform this function, these cells express a variety of pattern recognition receptors, including Toll-like receptors (TLRs). Mast cells respond to TLR ligands by secreting cytokines, chemokines, and lipid mediators, and some studies have found that TLR ligands can also cause degranulation, although this finding is contentious. In addition, stimulation via TLR ligands can synergize with signaling via the Fc epsilon RI, potentially enhancing the response of the cells to antigen in vivo. A great deal is now known about TLR signaling pathways. Some features of these pathways are cell type-specific, however, and work is under way to fully elucidate the TLR signaling cascades in the mast cell. Already, some interesting differences have been identified. This review aims to address what is known about the responses of mast cells to TLR ligands and the signaling pathways involved. Given the location of mast cells at sites exposed to the environment, the response of these cells to TLR ligands must be carefully regulated. The known mechanisms behind this regulation are also reviewed here.
引用
收藏
页数:13
相关论文
共 74 条
[11]   Stimulation of mast cells via FcER1 and TLR2: The type of ligand determines the outcome [J].
Fehrenbach, Kerstin ;
Port, Fillip ;
Grochowy, Gordon ;
Kalis, Christoph ;
Bessler, Wolfgang ;
Galanos, Chris ;
Krystal, Gerald ;
Freudenberg, Marina ;
Huber, Michael .
MOLECULAR IMMUNOLOGY, 2007, 44 (08) :2087-2094
[12]   Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2 [J].
Gantner, BN ;
Simmons, RM ;
Canavera, SJ ;
Akira, S ;
Underhill, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1107-1117
[13]   Integrated signalling pathways for mast-cell activation [J].
Gilfillan, AM ;
Tkaczyk, C .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (03) :218-230
[14]   Enhancement of Mast Cell IL-6 Production by Combined Toll-Like and Nucleotide-Binding Oligomerization Domain-Like Receptor Activation [J].
Haidl, Ian D. ;
McAlpine, Sarah M. ;
Marshall, Jean S. .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2011, 154 (03) :227-235
[15]   Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12 [J].
Hamerman, JA ;
Tchao, NK ;
Lowell, CA ;
Lanier, LL .
NATURE IMMUNOLOGY, 2005, 6 (06) :579-586
[16]   Role of phosphoinositide 3-kinase in innate immunity [J].
Hazeki, Kaoru ;
Nigorikawa, Kiyomi ;
Hazeki, Osamu .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (09) :1617-1623
[17]   Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cells [J].
Hochdoerfer, Thomas ;
Kuhny, Marcel ;
Zorn, Carolin N. ;
Hendriks, Rudi W. ;
Vanhaesebroeck, Bart ;
Bohnacker, Thomas ;
Krystal, Gerald ;
Huber, Michael .
CELLULAR SIGNALLING, 2011, 23 (05) :866-875
[18]   Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor at production [J].
Horwood, NJ ;
Mahon, T ;
McDaid, JP ;
Campbell, J ;
Mano, H ;
Brennan, FM ;
Webster, D ;
Foxwell, BMJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) :1603-1611
[19]   R-form LPS, the master key to the activation of TLR4/MD-2-positive cells [J].
Huber, M ;
Kalis, C ;
Keck, S ;
Jiang, ZF ;
Georgel, P ;
Du, X ;
Shamel, L ;
Sovath, S ;
Mudd, S ;
Beutler, B ;
Galanos, C ;
Freudenberg, MA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (03) :701-711
[20]   The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation [J].
Huber, M ;
Helgason, CD ;
Damen, JE ;
Liu, L ;
Humphries, RK ;
Krystal, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (19) :11330-11335